Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-500
Closed 4808
2022
Q4
$0 Sell
500
-441
-47% -$623 ﹤0.01% 5311
2022
Q3
$2K Sell
941
-7,472
-89% -$25.8K ﹤0.01% 4330
2022
Q2
$29K Buy
8,413
+2,700
+47% +$10.1K ﹤0.01% 2383
2022
Q1
$28K Buy
5,713
+1,763
+45% +$8.93K ﹤0.01% 2773
2021
Q4
$24K Buy
3,950
+800
+25% +$5.46K ﹤0.01% 2993
2021
Q3
$25K Sell
3,150
-5,164
-62% -$42.5K ﹤0.01% 3160
2021
Q2
$62K Buy
8,314
+2,235
+37% +$15.6K ﹤0.01% 2305
2021
Q1
$36K Sell
6,079
-3,403
-36% -$26.2K ﹤0.01% 2694
2020
Q4
$54K Sell
9,482
-12,806
-57% -$81.4K ﹤0.01% 1968
2020
Q3
$148K Buy
+22,288
New +$199K 0.01% 1085
2017
Q2
Sell
-646
Closed -$4K 7168
2017
Q1
$4K Hold
646
﹤0.01% 4972
2016
Q4
$8K Hold
646
﹤0.01% 4493
2016
Q3
$13K Hold
646
﹤0.01% 3925
2016
Q2
$9K Hold
646
﹤0.01% 4315
2016
Q1
$10K Hold
646
﹤0.01% 4068
2015
Q4
$13K Buy
+646
New +$14.2K ﹤0.01% 3888

Other funds holding VXRT

Cutler Group's VXRT Position: Q1 2023 in Review

Cutler Group sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 500 shares.

Cutler Group first reported a position in VXRT in Q4 2015 and held it in 16 quarters. The position peaked at $148K in Q3 2020. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Cutler Group reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 500 Vaxart shares in Q1 2023.
  • Cutler Group first reported a position in Vaxart in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Vaxart position peaked at $148K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.